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Abstract
Radioligand positron emission tomography (PET) with dual scan paradigms can provide valuable insight into changes in
synaptic neurotransmitter concentration due toexperimentalmanipulation. Theresidual t-test has been utilized toimprove the
sensitivity of the t-testinPET studies. However, nofurther developmentof statistical tests using residuals has been proposed so
far to be applied in cases when there are more than two conditions. Here, we propose the residual f-test, a one-way analysis of
variance (ANOVA), and examine its feasibility using simulated [
11C]raclopride PET data. We also re-visit data from our previously
published [
11C]raclopride PET study, in which 10 individuals underwent three PET scans under different conditions. We found
that the residual f-test is superior in terms of sensitivity than the conventional f-test while still controlling for type 1 error. The
test will therefore allow us to reliably test hypotheses in the smaller sample sizes often used in explorative PET studies.
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Introduction
Positron emission tomography (PET) is a widely used research
tool to assess the neurochemical changes induced by pharmacolog-
ical, behavioral or physiological intervention. Researchers measure
changes in binding potentials (BP) of radioactive tracers to receptor
sites, which is thought to reflect the synaptic concentration of the
targeted neurotransmitter [1]. Aston et al. [2] established a robust
voxel-wise method to test hypotheses with PET receptor parametric
mapping, i.e., the residual t-test. By utilizing the residuals of the
fitting in the simplified reference tissue model [3], this method
greatly increases the degree of freedom that determines the size of
the t-statistic considered significant. This is important because low
sample sizes, and thereforesmall degrees of freedom (and as a result,
low statistical power) are one of the major obstacles in costly PET
imagingstudies. Aston et al.’s method has been widely used in many
radio-ligand PET studies with repeated measures designs [4–12].
However, when there are more than two conditions, if we are to
take advantage of the large degree of freedom of the residual
method proposed by Aston et al. [2], we are limited to performing
multiple t-tests, thus increasing our chances of making a Type 1
error (i.e., false positive). In such cases, an analysis of variance
(ANOVA) performed prior to the t-tests would limit this problem.
In order to retain the benefits of using the residuals however, the
ANOVA (f-test) must first be converted into the ‘‘residual f-test’’.
Here, we propose the use of the residual f-test for testing
hypotheses when there are more than two conditions. In order to
demonstrate its usefulness, we simulated a series of [
11C]raclopride
PET images with different BPs. We then compared the number of
voxels showing a significant f-statistic when tested with the
conventional f-test, using SPM2 (Wellcome Department of
Cognitive Neurology, London, UK; http://www.fil.ion.ucl.ac.uk/
spm/), and when tested with the residual f-test. In addition, our
previously published data [9] was re-visited with the proposed
residual f-test to confirm its usefulness in reality.
Materials and Methods
Theory
Under the same assumption stated in Aston et al. [2], i.e., 1) the
residuals are not correlated in time; 2) the basis function fitting
method [3] is equivalent to a nonlinear least squares fit; 3) The only
sources of differences in parameter estimates among the scans are the
noise of the PET measurement and the biological effect of different
condition used in the PET scans; 4) The noisein the reference tissue is
negligible, if subjects underwent multiple numbers of scans in
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MSM and MSR are mean squares of the model and the residuals,
respectively. SSM and SSR are sums of squares of the model and the
residuals, respectively. dfM and dfR are the degrees of freedom of the
model and the residuals (NB the ‘‘residuals’’ we are referring to here
relate only to the calculation of MSR, and are different from the
residuals from the kinetic model used for the ‘‘residual f-test’’),
respectively. BPnk is estimated by a single PET image from a subject
(n)i nc o n d i t i o n( k). BPk is the mean BP of all subjects over condition
(k)andBPgrand is the mean BP over all images. As explained by Aston
et al. [2], the estimated dispersion matrix for all parameters [13] is :
var(^ b bnk)& _ f f i(^ b b
nk)
hi T _ f f i(^ b b
nk)
hi    {1
snk
2 ð2Þ
where ^ b b
nk is a vector of the parameter estimates (i.e., ^ b b
nk~
R1,nk,k2,nk,BPnk
   T), derived from the compartmental model fit of
the PET data [3], where fi(bnk) is the value of the operational





Ct and Cr is the concentration of radioligand in the tissue and the
reference region, respectively. R1 is the ratio of plasma to tissue
transport constant between tissue and reference region, k2 is the
plasma efflux constant.
Using the derivatives of the operational equation (Eq. 3), the
variances, snk









Where T is the number of frames of PET images and p is number
of parameters (R1, k2, BP). Zi is the residuals of the least square fit
of the operational equation (Eq. 3) at the i-th time point.
















Where var(BPnk) is taken from the estimated dispersion matrix of
BPnk [Eq 2 and 4]. As a result, the degree of freedom in equation
(Eq. 5) is increased compared to the standard f-test [K21,
KN2K] by an order of magnitude proportional to the number of
PET frames [K21, KN(T2p)2(k21)].
Simulation
We simulated realistic four dimensional [
11C]raclopride PET
images in two steps [2]. First, realistic time-activity-curves (TACs)
reflecting intervention-induced displacement of dopamine were
simulated using Matlab (R14SP3) from the real reference region
TAC obtained from [
11C]raclopride PET images for each of the
ten individuals acquired during our previous study [9]. The tissue
TACs were simulated using Eq. 3.
In order to reflect the intervention-induced focal changes in
[
11C]raclopride binding to dopamine receptors in the left caudate
nucleus, BP was varied for 0%, 25%, 210% and 220% from 3.0
while R1 was set to 1.39. TACs were also simulated for the rest of
the striatum (BP=3.0, R1=1.39), grey matter (BP=0.1, R1=1.0),
white matter (BP=0, R1=1.0), CSF (BP=0, R1=1.2), skin/skull/
muscle (BP=0, R1=0.3). k2 is set to 0.37 min
21. For the
cerebellum, real cerebellar TACs were used [9]. The parameters
for the striatum are employed from Farde et al. [15]. For other
regions, the parameters are employed from our previous real PET
data [9].
High-resolution MRI (GE Signa 1.5 T, T1-weighted images,
1 mm slice thickness) of each subject’s brain was acquired and
transformed into standardized stereotaxic space [16] using
automated feature-matching to the MNI template [17], then
segmented for striatum, grey matter, white matter, CSF, skin/
skull/muscle, and cerebellum [18]. The left caudate nucleus was
manually defined as a sphere located at X=212, Y=16, Z=8
(radius 6 mm, 99 voxels) (Fig. 1).
A total of 60 dynamic PET images (10 subjects66 different BP-
value for the left caudate, i.e., three 0%, one 25%, one 210%,
one 220%) were simulated from the labeled MRIs from each
subject [18] using PET–SORTEO [19,20], configured for the
Ecat Exact HR+ scanner operating in 3D mode. This simulator
Figure 1. Real and simulated PET images. (a) A labeled MRI of a
single subject. High-resolution MRI (GE Signa 1.5 T, T1-weighted
images, 1 mm slice thickness) of each subject’s brain was acquired and
transformed into standardized stereotaxic space [16] using automated
feature-matching to the MNI template [17], then segmented for
striatum (yellow), grey matter (light blue), white matter (dark green),
CSF (dark blue), skin/skull/muscle (light green), and cerebellum (not
shown) [18]. A spherical region-of-interest in the left caudate nucleus
was manually defined at X=212, Y=16, Z=8 (radius 6 mm, 99 voxels,
orange). (b) Real summed PET image of a single subject. (c) Simulated
summed PET image of a single subject with 0% changes in the left
caudate BP. (d) Simulated summed PET image of a single subject with
20% decrease in the left caudate BP. The reduced signal is apparent in
the left caudate nucleus (arrow).
doi:10.1371/journal.pone.0023298.g001
Residual F-Test
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given a numerical phantom description, the scanner geometry and
its physical characteristics. PET–SORTEO has been thoroughly
validated for the geometry of the Ecat Exact HR+ scanner and its
realistic noise representative of data collection process [19]. The
simulated detection system is made of 32 crystal rings with 576
detection units each, allowing the simultaneous acquisition of 63
transverse planes of 56.2 cm each over an axial extent of
15.52 cm.
The simulation of the transmission acquisition for each
numerical phantoms was performed following a standard 10 min
2-D acquisition protocol (span=15, maximum ring difference
(MRD)=7, lower level discriminator (LLD)=350, upper level
discriminator (ULD)=650) using the three rotating rod sources
(
68Ge, 200 Mbq each). Span and MRD refers to the geometry of
the acquisition. LLD and ULD are the energy threshold values in
between which the measured energy of a photon must lie in order
to be accepted. The 3-D correction factors were then derived for
each phantom from the simulated transmission scan in 3 steps.
First, the 2-D attenuation correction factors were computed from
the 2-D transmission data and a simulated blank scan. Then, an
attenuation map was reconstructed from the 2-D factors and
forward projected to generate the oblique correction factors,
leading to the set of 3-D attenuation correction factors.
Each of the 60 dynamic emission scans was simulated from the
numerical phantoms for the Ecat Exact HR+ scanner operating
in 3-D mode (span=9, mrd=22, lld=350, uld=650), then
normalized and corrected for randoms, scatter contamination,
attenuation, dead-time, and radioelement decay and finally recon-
structed using a standard 3D filtered back projection algorithm
with the Hanning filter and a cutoff frequency of 0.5 mm. Each
reconstruction yielded 29 time frames (661 min, 2062 mins,




11C]raclopride BP was calculated using a simplified
reference tissue (cerebellum) method [3,14]. Durbin-Watson
statistics [21] was evaluated to ensure the feasibility of using
residuals for estimation of standard deviation [2].
In order to evaluate the sensitivity of the residual f-test, different
combinations of three conditions were then chosen to undergo
both the conventional f-test using SPM2 and residual f-test
(Table 1). Residual f-statistics greater than 15.3 (n=10) and 15.6
(n=6) were considered significant, determined by resel correction
(p,0.001 corrected) [22]. Conventional f-statistics determined by
SPM2 were considered significant using family-wise-error (FWE;
p,0.05 corrected).
Specificity, i.e., weather the f-statistics detects false positives, was
also compared between the residual f-test and conventional f-test
(Table 2).
PET analysis
Previously published data [9] with [
11C]raclopride PET was re-
analyzed with the proposed one-way ANOVA (i.e., residual f-test).
In brief, ten normal right-handed subjects (20–28 years; four
males) underwent three scans on three different days after the
procedures were approved by the local research ethics committee
and informed consent was obtained. Continuous theta burst
stimulation (cTBS) was applied to three different targets; the right
dorsolateral prefrontal cortex (DLPFC), left DLPFC and vertex
(control site) per each day. After cTBS, subjects performed the
montreal card sorting task (MCST), which has previously been
shown to induce striatal dopamine release compared to a control
condition [11]. PET frames were summed, registered to the
corresponding MRI [23] and transformed into standardized
stereotaxic space using the transformation parameters previously
determined for the MRI [17]. Voxelwise [
11C]raclopride BP was
calculated using a simplified reference tissue (cerebellum) method
[3,14]. Durbin-Watson statistics [21] was performed to ensure the
feasibility of using residuals for estimation of standard deviation
[2]. For statistical analysis, residual f-statistics greater than 15.3
were considered significant (p,0.001 corrected) [22]. Conven-
tional f-statistics determined by SPM2 were considered significant
using family-wise-error (FWE; p,0.05 corrected).
Results
A summary of the simulation study is shown in Table 1. With 6
randomly selected subjects, the residual f-test successfully identified
the significant effect of condition in the left caudate, while the
conventional f-test did not, especially when there were less
prominent changes in BP (i.e., 5%–10% change). When the
changes in BP were more prominent (i.e., 20% change), the
Table 1. Sensitivity of different f-test from simulated [
11C]raclopride PET.





(p,0.05, corrected) Max f
number of voxels
(p,0.001, corrected)
0, 0, 5% 6 15.2 0 18.1 2
0, 5, 10% 6 33.0 0 26.5 20
0, 0, 10% 6 52.2 1 33.5 44
0, 10, 20% 6 147.0 51 120.5 127
0, 0, 20% 6 199.3 46 147 151
0, 0, 5% 10 17.5 0 15.7 2
0, 5, 10% 10 32.7 2 22.9 12
0, 0, 10% 10 34.0 16 28.3 31
0, 10, 20% 10 162.6 101 107.1 112
0, 0, 20% 10 196.9 122 135.8 141
BP was modulated for 99 voxels in the left caudate nucleus (spherical VOI centered at X=212, Y=16, Z=8 with 6 mm radius).
Max f reflects the highest f-value observed in the f-test parametric map.
doi:10.1371/journal.pone.0023298.t001
Residual F-Test
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less voxels were identified compared with the residual f-test, i.e., 46–
51 voxels vs. 127–151 voxels, respectively. When 10 subjects were
included in the analysis, both statistical tests identified a similar
number of voxels as having significantly different BPs, with the
residual f-test spotting slightly more voxels than the conventional f-
test, i.e., 2–141 voxels vs. 0–122 voxels, respectively.
No false positives were detected in either method when no
changes in BP were simulated (p,0.001 corrected) (Table 2). When
a less stringent threshold was applied(i.e., p,0.05or p,0.01),a few
falsepositivesweredetected when usingthe residualf-testwhen only
six subjects were included. The conventional f-test did not produce
any false positives when corrected for multiple comparisons
(Table 2).
Our previously published data [9], when re-visited with the
residual f-test, revealed that the residual f-test would have confirmed
our significant effect of cTBS on task-induced dopamine release in
the left caudate (X=212, Y=8, Z=14, f=17.9, p,0.001
corrected, Table 3), right caudate (X=20, Y=8, Z=14, f=23.8,
p,0.001 corrected) and left putamen (X=222, Y=6, Z=2,
f=24.0, p,0.001 corrected), i.e., the same regions that were
previously reported after using the t-test between left DLPFC and
vertexstimulation(Fig.2) [9]. In contrast, the conventionalf-testdid
not detect any significant voxels at p,0.05 (corrected).
No autocorrelation of residuals were detected as the Durbin-
Watson statistic was higher than its upper limit (.1.65, k=3,
n=30) in all simulated and real data in the striatum (Fig. 3).
Discussion
We have demonstrated the superior sensitivity of a residual f-test
on simulated data as compared to the conventional f-test.
Qualitatively, the f-statistics were not very different between the
two methods (Table 1), but the greater degree of freedom of the
residual f-test lowered the corrected threshold for significance.
Indeed, using the conventional f-test, the number of voxels
identified to have significant f-values was increased when more
subjects were included in the analysis. However, this trend was not
observed when using residual f-test, possibly due to the ceiling
effect of the high degree of freedom utilized in the residual f-test,
which in theory allows us to perform the test on a smaller number
of subjects [2]. However, in practice, the number of subjects
required for valid statistical tests should be determined after
considering the test-retest variability, counter-balancing of scan
orders and other underlying noise that may present. Nevertheless,
neither method detected any false positives in the simulation study
at the given p-threshold (p,0.001 corrected for residual f-test;
p,0.05 corrected for conventional f-test; Table 2), thus we
propose that the residual f-test can be applied successfully to
increase the sensitivity of receptor-ligand PET studies without
generating false positives.
It must be noted that when the threshold for significance in the
residual f-test is lowered to p,0.01, some false positives were
identified when only six subjects were included in the analysis,
while the conventional f-test did not (Table 2). This may suggest
that the specificity of the residual f-test is not as robust as the
conventional f-test. However, the sensitivity of the conventional f-
test is considerably lower than residual f-test, as it failed to detect
significant f-statistics when the changes in BP were subtle (Table 1).
Nevertheless, in order to compensate for the lower robustness of
the residual f-test in controlling type 1 error compared to the
conventional f-test, we recommend thresholding p at ,0.001
rather than p,0.05 to determine significant voxels when using the
residual f-test. This practice will ensure greater control of false
positives while preserving the high sensitivity of the residual f-test.
The superior sensitivity of residual f-test when only a small
change in BP (i.e., 5–10%) was induced is of particular interest to
many PET imaging researchers. In fact, a recent review of PET
studies that investigated behavior-induced dopamine release
summarized that a third of the reviewed studies reported less
than 10% change in the radioligand BP [24]. While increasing the
sample size may provide enough statistical power to detect small
changes in BP, it is desirable to also to try to minimize the sample
size not only for research costs but also for ethical reasons.
Using the residual f-test we were able to successfully replicate
our previous study [9] in which we showed only left DLPFC
stimulation increased [
11C]raclopride binding while right DLPFC
stimulation did not compared to vertex stimulation. As the right
Table 2. Specificity of different f-test from simulated [
11C]raclopride PET.
conventional f-test (corrected) residual f-test (corrected)
number of subject p-threshold f-threshold number of voxels f-threshold number of voxels
6p ,0.05 *39.1 0 11.3 6
p,0.01 55.9 0 13.0 2
p,0.001 91.5 0 **15.6 0
10 p,0.05 *20.6 0 11.0 0
p,0.01 26.4 0 12.6 0
p,0.001 36.8 0 **15.3 0
Three conditions per subject have been included in the f-test. BP was not changed in all three conditions.
*f-statistics are considered significant at p,0.05 (corrected) for conventional f-test.
**f-statistics are considered significant at p,0.001 (corrected) for residual f-test.
doi:10.1371/journal.pone.0023298.t002
Table 3. Peak-cluster identified in the left caudate nucleus
using different f-tests from real [
11C]raclopride PET study [9].
p-threshold f-threshold Max f number of voxels
residual f-test ,0.001 corr. 15.3 17.9 4
conventional f-test ,0.05 corr. 20.8 7.5 0
,0.001 uncorr. 10.4 7.5 0
doi:10.1371/journal.pone.0023298.t003
Residual F-Test
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the f-map (Fig. 2b) shows a similar pattern to the t-map, i.e. left
DLPFC vs. vertex stimulation (Fig. 2a). In contrast, the conven-
tional f-test could only detect significant voxels if no correction for
multiple comparisons was applied [9].
The residual f-test extends the residual t-test, proven to be more
sensitive than the conventional t-test [2], for cases in which more
than two conditions are included in the study design. Therefore,
not only does it have the same advantages that the residual t-test
has, but also its limitations, e.g., motion related artifacts and inter-
subject variability in anatomy and baseline BP. Although we tried
to maximize the influences of realistic variables into the
simulation, real cerebellar TACs and real anatomical segmented
MRIs, it was not possible to employ motion artifact by using PET-
SORTEO. Head motion between PET frames may introduce
more fluctuation in the TAC, which may increase the residuals of
model fitting [3]. This may reduce the f-values in the residual f-
test, but not in the standard f-test. However, head movement
between frames can be easily overcome by employing frame-by-
frame motion correction methods in the analysis [25,26]. On the
other hand, head motion within PET frames may over- or under-
estimate TACs depending on the shape of movement and regions,
and it is difficult to predict its effect on either type of f-statistics.
We chose to simulate [
11C]raclopride since it is the most widely
used neuroreceptor ligand that has been used to investigate
neurotransmitter displacement [1,24]. In addition, we evaluated
the feasibility of utilizing residuals in the t or f-statistics and
confirmed no presence of autocorrelation for [
11C]raclopride PET
(Fig. 3). Although there are no obvious reasons not to extrapolate
the usage of residual f-test toward other ligands, one should
consider the possibility that differences in kinetics may affect the
computing of the standard deviation of BP from the residuals of
the model fitting [2]. Nonetheless, the superiority of the residual f-
test may be even more valuable in certain neuroreceptor ligand
PET studies whose search regions are beyond the small structures
such as the striatum, e.g., [
11C]FLB 457 [8,27,28], since these
require a greater degree of correction for multiple comparisons
[22,29].
Given that we used PET–SORTEO, a realistic PET simulator
based on real individual MRIs [19,20], the role of partial volume
effects (PVE) should also be taken into consideration [30–32]. The
PVE may have broadened but lowered the effect of varying BPs in
simulation. For example, when 20% changes in BP were simulated
with 10 subjects, the cluster sizes that were identified by both
statistical tests were .100 while only 99 voxels were manipulated
(Table 1). Several methods have been proposed for correcting
PVE [33]. Therefore, further studies with different PVE correction
methods are encouraged to potentially increase the sensitivity of
the residual f-test.
Figure 3. Averaged Durbin-Watson statistics-map over 10
subjects with (a) real [
11C]raclopride PET and (b) simulated
[
11C]raclopride PET. All PET images from both real and simulated
data passed the Durbin-Watson test, i.e., the statistics were .1.65 [21].
doi:10.1371/journal.pone.0023298.g003
Figure 2. The similar results of t-test and f-test on real data. (a)
t-test between left DLPFC stimulation vs. vertex stimulation (control
condition): The t-map is overlaid upon the averaged MRI of all subjects
in standard MNI space (published with permission from Ko et al. [9]). (b)
f-test of all three stimulation condition (left DLPFC, right DLPFC and
vertex stimulation): As the right DLPFC stimulation had no significant
effect on BP in these regions, the f-map shows the similar pattern of t-
map of left DLPFC vs. vertex stimulation.
doi:10.1371/journal.pone.0023298.g002
Residual F-Test
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PET scans [9], thus the TAC simulation of other brain regions
(Eq. 3) are likely contaminated by partial volume effect. This may
have reduced the signal-to-noise ratio and resulted in less realistic
simulation of dynamic PET images. However, the cerebellum is
fairly a large structure and we carefully delineated the cerebellum
to only include grey matter. It has been previously reported that
the recovery coefficient for 13.0 mm-diameter cylindrical phan-
tom is higher than 90% when the image is reconstructed with
5 mm full-width-half-maximum ramp filter [30]. Therefore, the
partial volume effect introduced by the use of real cerebellar TAC
might have been insignificant.
The PET-SORTEO simulation was performed on each
individual’s segmented MRIs after transformation into the
standard space to simplify the simulation procedures (c.f.,
[34,35]). This may have reduced the realistic errors of co-
registration/normalization of simulated PET images, which may
have improved the signal-to-noise ratio compared to real PET
experiment. However, the conventional f-test was also performed
on the same PET images, therefore both types of f-tests were
compared at the same level of noise environment.
In conclusion, we propose a ‘‘residual f-test’’, based on the
residual t-test [2], for use in PET study designs involving more
than two conditions. This test allows us to take advantage of larger
degrees of freedom than afforded when using the standard f-test,
and therefore mitigates the increased susceptibility to type 2 errors
inherent to PET studies with small sample sizes.
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